CME webinar: Provider Diagnosis Documentation Improvement

Jul. 2024Education/Webinars

Please join UPMC Health Plan’s Risk Adjustment/HCC Coding Education Program Director Marlana Tice for a live, continuing medical education (CME)-accredited webinar on Thursday, Sept. 26, from noon to 1 p.m., that will deliver an overview on provider diagnosis documentation improvement.

During this presentation, we will provide a comprehensive overview of official documentation and coding guidelines needed for proper reporting, focusing on:

  • Gaining awareness that supporting diagnosis codes in the medical record also supports the level of medical decision making that in turns drives E&M code assignment.
  • Reviewing common provider diagnosis documentation deficiencies in the E&M record.
  • Demonstrating an understanding of official documentation and coding guidelines for proper ICD-10-CM code reporting.
  • Building skills of best practice documentation to support ICD-10-CM diagnosis codes.

Presenter: Marlana R. Tice, BA, CCS-P, CPC, CCS,
AHIMA-Approved ICD-10-CM/PCS Trainer,
Program Director, Risk Adjustment-HCC Coding Education, UPMC Health Plan

Register now. This webinar will be recorded.

Certified coders may earn 1.0 CEU from the American Academy of Professional Coders (AAPC).

This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.

You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility.


Recent Announcements

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates

Medicaid provider update: High-cost Medicaid drug billing

Billing requirements for Medicaid-covered drugs
Nov. 2025Important Notices

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Nov. 2025Education/Webinars